TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12716269

Group type: EXPERIMENTAL
Intervention: Homeopathic treatment (individually tailored remedy)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 10715299

Group type: EXPERIMENTAL
Intervention: IV methotrexate (MTX) 1,000 mg/m2 plus IV mercaptopurine (MP) 1,000 mg/m2 (regimen A)
Number of subjects: 651

Group type: COMPARATOR
Intervention: IV methotrexate (MTX) 1,000 mg/m2 alone (regimen C)
Number of subjects: 651

Group type: COMPARATOR
Intervention: Both regimens (A and C)
Number of subjects: 651
Study: 9088362

Group type: EXPERIMENTAL
Intervention: Standard advisory letter
Number of subjects: 28000

Group type: EXPERIMENTAL
Intervention: Soft-sell advisory letter
Number of subjects: 28000

Group type: COMPARATOR
Intervention: Control group (no letter)
Number of subjects: 28000

Group type: EXPERIMENTAL
Intervention: Both letters (standard and soft-sell)
Number of subjects: 28000
Study: 8330937

Group type: EXPERIMENTAL
Intervention: Cermet ionomer cement with varnish
Number of subjects: 54

Group type: COMPARATOR
Intervention: Amalgam with cavity varnish
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Cermet ionomer cement without varnish
Number of subjects: 54
Study: 2941771

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28508559

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO, 90 gCHO hour-1)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (PLA, 0 gCHO hour-1)
Number of subjects: 18
Study: 26716365

Group type: EXPERIMENTAL
Intervention: Daily text messages for adherence for 21 days plus usual care
Number of subjects: 75

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 75
Study: 24556879

Group type: EXPERIMENTAL
Intervention: Foldable hydrophilic acrylic IOL through a 2.5‐mm corneal incision
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Rigid PMMA IOL via a 5‐mm sclerocorneal tunnel
Number of subjects: 1200
Study: 23299530

Group type: EXPERIMENTAL
Intervention: Cediranib 20 mg with mFOLFOX6
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Cediranib 30 mg with mFOLFOX6
Number of subjects: 210

Group type: COMPARATOR
Intervention: Bevacizumab with mFOLFOX6
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Cediranib 30 mg
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Cediranib 20 mg
Number of subjects: 210

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 210
Study: 19900491

Group type: EXPERIMENTAL
Intervention: GLP-2 (450 nmol subcutaneous)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 10
Study: 17901967

Group type: EXPERIMENTAL
Intervention: Hypobaric conditions
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Humid conditions
Number of subjects: 75

Group type: COMPARATOR
Intervention: Hyperbaric conditions
Number of subjects: 75

Group type: COMPARATOR
Intervention: Relatively dry conditions
Number of subjects: 75
Study: 15935648

Group type: EXPERIMENTAL
Intervention: Chlorhexidine spray (0.5% in alcoholic solution)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chlorhexidine sachet (0.05% aqueous solution)
Number of subjects: 100
Study: 12930191

Group type: EXPERIMENTAL
Intervention: 180 g EGb 761
Number of subjects: 20
Study: 10616614

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0
Study: 8914119

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (tryptophan deficient amino acid mixture)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nutritionally balanced amino acid mixture containing tryptophan (control)
Number of subjects: 0
Study: 1860302

Group type: EXPERIMENTAL
Intervention: Ranitidine pretreatment (five 150-mg oral doses given every 12 hours)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No ranitidine pretreatment (control)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ranitidine pretreatment
Number of subjects: 12
Study: 7334938

Group type: EXPERIMENTAL
Intervention: Tablets containing 2 mg of micronized oestradiol and 1 mg of micronized oestriol (Estrofem)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Aqueous suspension of the same micronized hormones
Number of subjects: 10
Study: 30977122

Group type: EXPERIMENTAL
Intervention: Ventriculo-amniotic shunting
Number of subjects: 44
Study: 28625387

Group type: EXPERIMENTAL
Intervention: In-hospital influenza vaccination
Number of subjects: 4400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4400
Study: 26764121

Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA) 30 mg administered every 7 days (Q7D)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA) 30 mg administered every 5 days (Q5D)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA) 30 mg
Number of subjects: 23
Study: 24796046

Group type: COMPARATOR
Intervention: CC + Zhangmo decoction group (C)
Number of subjects: 160

Group type: COMPARATOR
Intervention: CC + Zhangmo decoction + warm needling group (D)
Number of subjects: 160

Group type: COMPARATOR
Intervention: CC + progynova group (B)
Number of subjects: 160
Study: 21254195

Group type: EXPERIMENTAL
Intervention: Mean USS
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: Sum USS
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: USS scores
Number of subjects: 1063
Study: 18815997

Group type: EXPERIMENTAL
Intervention: 14-week integrated treatment targeting anger and addictions (i.e., both gambling and substance use)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Specialized treatment-as-usual (TAU) for gambling and substance use
Number of subjects: 42
Study: 17189398

Group type: EXPERIMENTAL
Intervention: 400 mg sorafenib twice daily plus best supportive care
Number of subjects: 902

Group type: COMPARATOR
Intervention: Placebo plus best supportive care
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: 400 mg sorafenib twice daily
Number of subjects: 902
Study: 12602772

Group type: EXPERIMENTAL
Intervention: Rank tests for clustered survival data (logrank and Wilcoxon tests)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard rank tests for independent survival data
Number of subjects: 0
Study: 11025377

Group type: EXPERIMENTAL
Intervention: Doxazosin GITS 4 or 8 mg once daily
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Doxazosin standard 1 mg to 8 mg once daily
Number of subjects: 795

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Doxazosin GITS
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Doxazosin standard
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Doxazosin GITS and Doxazosin standard
Number of subjects: 795
Study: 8765624

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (6 mg/kg per week)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Oral ferrous lactate (elemental iron, 12 mg/kg per day)
Number of subjects: 42
Study: 1576562

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 4016494

Group type: EXPERIMENTAL
Intervention: Abdominal lymphoscintigraphy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Lymphography
Number of subjects: 32
Study: 30867553

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of the supero-lateral branch of the medial forebrain bundle (slMFB)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 16
Study: 28642209

Group type: EXPERIMENTAL
Intervention: Daily oral naltrexone (50mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 26138865

Group type: EXPERIMENTAL
Intervention: Empagliflozin 5 mg BID
Number of subjects: 16

Group type: COMPARATOR
Intervention: Empagliflozin 10 mg QD
Number of subjects: 16
Study: 23439620

Group type: EXPERIMENTAL
Intervention: High socioeconomic status
Number of subjects: 375

Group type: COMPARATOR
Intervention: Low socioeconomic status
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Presence of chronic health conditions
Number of subjects: 375

Group type: COMPARATOR
Intervention: Absence of chronic health conditions
Number of subjects: 375
Study: 21482091

Group type: EXPERIMENTAL
Intervention: 18 μg of tiotropium bromide plus 200 μg salbutamol
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 19197768

Group type: EXPERIMENTAL
Intervention: Early Start Plus (ESP)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Early Start (ES)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Control (untreated alcohol users)
Number of subjects: 298
Study: 16999641

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 20
Study: 12919709

Group type: EXPERIMENTAL
Intervention: Cyclic therapy with etidronate (400 mg/day for 2 weeks followed by 500 mg/day of calcium lactate for 12 weeks, repeated every 14 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 52
Study: 11006672

Group type: EXPERIMENTAL
Intervention: Structured methadone maintenance protocol introduced in general practice.
Number of subjects: 54

Group type: COMPARATOR
Intervention: Before the introduction of structured methadone maintenance.
Number of subjects: 54
Study: 9344053

Group type: EXPERIMENTAL
Intervention: Respiration monitoring during feeding
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Videofluoroscopy with simultaneous respiration monitoring
Number of subjects: 28
Study: 1438625

Group type: EXPERIMENTAL
Intervention: Haloperidol treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 19
Study: 3824375

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg twice daily after breakfast and at bedtime
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cimetidine 200 mg four times daily
Number of subjects: 0
Study: 31515625

Group type: EXPERIMENTAL
Intervention: Robotic/endoscopic thyroidectomy via gasless unilateral axillary approach
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Robotic/endoscopic thyroidectomy via postauricular facelift approach
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional transcervical thyroidectomy
Number of subjects: 100
Study: 30425104

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure (BP) control
Number of subjects: 2486

Group type: EXPERIMENTAL
Intervention: FGF23
Number of subjects: 2486
Study: 26433135

Group type: EXPERIMENTAL
Intervention: Hospice services received over a four week period
Number of subjects: 0
Study: 24246819

Group type: EXPERIMENTAL
Intervention: SIPsmartER intervention aimed at decreasing sugar-sweetened beverage consumption over 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: MoveMore control group focused on physical activity promotion
Number of subjects: 0
Study: 22212173

Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20105416

Group type: EXPERIMENTAL
Intervention: Posttreatment depressive symptoms
Number of subjects: 1726

Group type: EXPERIMENTAL
Intervention: Pretreatment depressive symptoms
Number of subjects: 1726
Study: 18703607

Group type: EXPERIMENTAL
Intervention: PET scans in group A
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: PET scans in group B
Number of subjects: 191
Study: 16219630

Group type: EXPERIMENTAL
Intervention: School Fruit Programme (no parental cost)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Control schools (no intervention)
Number of subjects: 517
Study: 12668820

Group type: EXPERIMENTAL
Intervention: Day-surgery stapled haemorrhoidectomy
Number of subjects: 48

Group type: COMPARATOR
Intervention: In-patient stapled haemorrhoidectomy
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups (Day-surgery and In-patient)
Number of subjects: 48
Study: 10750210

Group type: EXPERIMENTAL
Intervention: Estimation of absolute cardiovascular risk by general practitioners and practice nurses
Number of subjects: 0
Study: 9041463

Group type: EXPERIMENTAL
Intervention: Low-dose IFN, 6 x 10(6) U/m2 daily x 3 every 4 weeks
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: High-dose IFN, 12 x 10(6) U/m2, 3 x/week
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Both low-dose and high-dose IFN
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: High-dose IFN
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Patients receiving >= 6 weeks of therapy
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Overall response to IFN
Number of subjects: 71
Study: 1424422

Group type: EXPERIMENTAL
Intervention: Fluoxetine (40 mg/day)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 6366561

Group type: EXPERIMENTAL
Intervention: Nifedipine (60 mg per day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol (240 mg per day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg per day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31018810

Group type: EXPERIMENTAL
Intervention: Low-frequency right-sided repetitive transcranial magnetic stimulation (LFR rTMS) over the right dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-frequency right-sided repetitive transcranial magnetic stimulation (LFR rTMS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 30
Study: 28329789

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (Med diet)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with Coenzyme Q10 (Med + CoQ)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Western high-saturated-fat diet (SFA diet)
Number of subjects: 20
Study: 27430920

Group type: EXPERIMENTAL
Intervention: EBUS‐GS‐TBLB with VBN
Number of subjects: 184

Group type: COMPARATOR
Intervention: EBUS‐GS‐TBLB without VBN
Number of subjects: 184
Study: 25034547

Group type: EXPERIMENTAL
Intervention: Interval training (9 to 5 X 1000 m)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Continuous training (9000 to 5000 m)
Number of subjects: 24
Study: 22573431

Group type: EXPERIMENTAL
Intervention: Vitamin D (400 IU/day) and Calcium (1,000 mg elemental)
Number of subjects: 36282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36282
Study: 20147467

Group type: EXPERIMENTAL
Intervention: Vegetable portion size increased (180, 270, or 360 g)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Substitution of vegetable for grain and meat
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Reduction in vegetable energy density (0.8 or 0.4 kcal/g)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Combination of substitution and reduction in energy density
Number of subjects: 97
Study: 18949299

Group type: COMPARATOR
Intervention: No preflaring (Group 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cervical preflaring with LA Axxess burs (Group 5)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cervical preflaring with EndoFlare instruments (Group 4)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cervical preflaring with Gates‐Glidden drills (Group 2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cervical preflaring with ProTaper instruments (Group 3)
Number of subjects: 50
Study: 15793271

Group type: EXPERIMENTAL
Intervention: Communication group watching a videotape about communicating and managing postoperative pain
Number of subjects: 38

Group type: COMPARATOR
Intervention: Comparison group watching a videotape about managing postoperative pain only
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Communication group
Number of subjects: 38
Study: 12395916

Group type: EXPERIMENTAL
Intervention: Pueraria thomsonii dried flower extracts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 0
Study: 10066201

Group type: EXPERIMENTAL
Intervention: One neonatal screening examination (one screen policy)
Number of subjects: 9712

Group type: COMPARATOR
Intervention: Two neonatal screening examinations (two screen policy)
Number of subjects: 9712
Study: 7738889

Group type: EXPERIMENTAL
Intervention: Ultrasonography (US)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Intravenous cholangiography (IVC)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Comparison of US and IVC
Number of subjects: 67
Study: 1917621

Group type: EXPERIMENTAL
Intervention: Overall treatment time within 49 days (≤ 7 weeks)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Overall treatment time 50 to 63 days (8 to 9 weeks)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Overall treatment time ≥ 64 days (> 9 weeks)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Gleason scores 2-5
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Gleason scores 6-7
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Gleason scores 8-10
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Incidence of late complications
Number of subjects: 780
Study: 7470200

Group type: EXPERIMENTAL
Intervention: Probucol
Number of subjects: 5
Study: 30900733

Group type: EXPERIMENTAL
Intervention: Combined anterior and posterior 2‐segment spinal fusion
Number of subjects: 27

Group type: COMPARATOR
Intervention: Posterior 3‐segment spinal fusion
Number of subjects: 27
Study: 28490557

Group type: EXPERIMENTAL
Intervention: empagliflozin
Number of subjects: 34

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 34
Study: 25668435

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin administration (24 IU)
Number of subjects: 66
Study: 25132201

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 70
Study: 22968100

Group type: EXPERIMENTAL
Intervention: Conventional fast-food meal (hamburger meal, glycemic load = 48.7)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Unconventional fast-food meal (salmonburger meal, glycemic load = 46.0)
Number of subjects: 25
Study: 19336851

Group type: EXPERIMENTAL
Intervention: 2% amitriptyline gel
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 17417723

Group type: EXPERIMENTAL
Intervention: Expanded cardiac rehabilitation
Number of subjects: 224

Group type: COMPARATOR
Intervention: Routine rehabilitation
Number of subjects: 224
Study: 15021286

Group type: EXPERIMENTAL
Intervention: Bioject jet injector
Number of subjects: 40

Group type: COMPARATOR
Intervention: 25G needle injection
Number of subjects: 40
Study: 11685307

Group type: EXPERIMENTAL
Intervention: Pressure support of 10 cmH2O
Number of subjects: 257

Group type: COMPARATOR
Intervention: T‐piece
Number of subjects: 257
Study: 9673757

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 7521559

Group type: EXPERIMENTAL
Intervention: Specific reading retardation group (n = 37)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Control group with normal intelligence (n = 285)
Number of subjects: 399
Study: 2510329

Group type: EXPERIMENTAL
Intervention: Enoxacin 400 mg
Number of subjects: 152

Group type: COMPARATOR
Intervention: Ceftriaxone 250 mg IM
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Enoxacin
Number of subjects: 152

Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Enoxacin and Ceftriaxone
Number of subjects: 152
Study: 941915

Group type: EXPERIMENTAL
Intervention: Cephalothin
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Cephapirin
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Scalp vein needles
Number of subjects: 82

Group type: COMPARATOR
Intervention: Plastic catheters
Number of subjects: 82
Study: 31025385

Group type: EXPERIMENTAL
Intervention: Ultrafine granular powder (UGP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrafine powder (UP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional decoction pieces (TDP)
Number of subjects: 0
Study: 28984772

Group type: EXPERIMENTAL
Intervention: Group A: fluid‐air exchange tube connected to a 1 mL syringe with the plunger removed and the tip dilated with a hemostat.
Number of subjects: 86

Group type: COMPARATOR
Intervention: Group B: tip of the syringe closely attached to the cap of the 23‐gauge cannula by a tube adaptor.
Number of subjects: 86
Study: 25567410

Group type: EXPERIMENTAL
Intervention: Local mild hypothermia with conventional mannitol (Group A)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional mannitol (Group B)
Number of subjects: 36
Study: 23699977

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab, 0.5 mg
Number of subjects: 789

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 789

Group type: EXPERIMENTAL
Intervention: Best-corrected visual acuity improvement
Number of subjects: 789
Study: 21168116

Group type: EXPERIMENTAL
Intervention: Qigong training for half an hour daily for six weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no Qigong training during the first six weeks)
Number of subjects: 37
Study: 19066368

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU every other day)
Number of subjects: 14641

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg daily)
Number of subjects: 14641
Study: 17122713

Group type: EXPERIMENTAL
Intervention: Unannounced standardized patients (SPs)
Number of subjects: 242
Study: 15015606

Group type: EXPERIMENTAL
Intervention: Endoscopic stenting
Number of subjects: 22

Group type: COMPARATOR
Intervention: Colostomy
Number of subjects: 22
Study: 11409458

Group type: EXPERIMENTAL
Intervention: Short anatomic femoral stem
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control side (contralateral side)
Number of subjects: 24
Study: 9759611

Group type: EXPERIMENTAL
Intervention: GPIIb/IIIa‐inhibitor MK383
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heparin (0.2 U/ml)
Number of subjects: 0
Study: 7886407

Group type: COMPARATOR
Intervention: Furosemide with placebo pre-treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Furosemide with captopril pre-treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Furosemide with prazosin pre-treatment
Number of subjects: 0
Study: 3229117

Group type: EXPERIMENTAL
Intervention: Small doses of heparin (2 X 5000 u. subcutaneously/24 h)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Moderate exercise (dorsal and plantar flexion of the foot for one minute each hour)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 408